Related Experiment Video

Updated: Jan 24, 2026

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
05:39

Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

Published on: May 16, 2025

589

[Progressive Multifocal Leukoencephalopathy in Systemic Lupus Erythematosus]

Motohiro Yukitake1

  • 1Neurology, Kouhoukai Takagi Hospital.

Brain and Nerve = Shinkei Kenkyu No Shinpo
|May 16, 2019
PubMed

Insights

Progressive multifocal leukoencephalopathy (PML) is a rare but serious risk, especially with disease-modifying therapies (DMTs). Careful monitoring for PML is crucial in patients with systemic lupus erythematosus (SLE) undergoing treatment.

Area of Science:

  • Neurology
  • Immunology
  • Pharmacology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare demyelinating disease of the central nervous system.
  • PML can occur in immunocompromised individuals, including those with systemic lupus erythematosus (SLE).
  • The emergence of disease-modifying therapies (DMTs) has introduced a new category of PML risk, particularly in multiple sclerosis.

Purpose of the Study:

  • To review the occurrence and implications of PML in patients with SLE.
  • To highlight the increasing concern of DMT-associated PML in the context of SLE treatment.
  • To emphasize the need for careful consideration of PML risk during SLE management.

Main Methods:

  • Literature review of PML cases in SLE patients.
  • Analysis of PML incidence associated with conventional and DMTs in SLE.
  • Discussion of diagnostic and monitoring strategies for PML in SLE.

Main Results:

  • PML is a rare but significant adverse event in SLE.
  • DMT-associated PML is an emerging concern, extending beyond multiple sclerosis.
  • The risk of PML must be evaluated for both conventional and novel DMTs used in SLE treatment.

Conclusions:

  • Clinicians must be vigilant for PML in SLE patients, considering all therapeutic agents.
  • Early recognition and management of PML are critical for patient outcomes.
  • The evolving landscape of DMTs necessitates ongoing assessment of PML risks in SLE management.

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.6K
Multifocal Electroretinograms16:49

Multifocal Electroretinograms

Published on: December 4, 2011

18.9K

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.3K
Second Order systems II01:18

Second Order systems II

In an underdamped second-order system, where the damping ratio ζ is between 0 and 1, a unit-step input results in a transfer function that, when transformed using the inverse Laplace method, reveals the output response. The output exhibits a damped sinusoidal oscillation, and the difference between the input and output is termed the error signal. This error signal also demonstrates damped oscillatory behavior. Eventually, as the system reaches a steady state, the error diminishes to zero.
396
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.7K
First Order Systems01:21

First Order Systems

First-order systems, such as RC circuits, are foundational in understanding dynamic systems due to their straightforward input-output relationship. Analyzing their responses to different input functions under zero initial conditions reveals significant insights into system behavior.
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
411
Second Order systems I01:20

Second Order systems I

A servo system exemplifies a second-order system, featuring a proportional controller and load elements that ensure the output position aligns with the input position. The relationship between these components is described by a second-order differential equation. Applying the Laplace transform under zero initial conditions yields the transfer function, showing how inputs are converted to outputs in the system.
By reinterpreting the system, one can derive the closed-loop transfer function, which...
581
Classification of Systems-I01:26

Classification of Systems-I

Linearity is a system property characterized by a direct input-output relationship, combining homogeneity and additivity.
Homogeneity dictates that if an input x(t) is multiplied by a constant c, the output y(t) is multiplied by the same constant. Mathematically, this is expressed as:
555